Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Chlamydia trachomatis and Neisseria gonorrhoeae in Pregnancy: Trends in United States, 2010–2018

Chlamydia trachomatis and Neisseria gonorrhoeae in Pregnancy: Trends in United States, 2010-2018

Authors: Niles JK, Kaufman HW, Peterman TA, Tao G, Gift TL, Alagia DP. 

Citation: Sex Transm Dis. 2021 Jul 5. doi: 10.1097/OLQ.0000000000001504. Online ahead of print.

Specialties: Infectious Disease, Women's Health/OB/GYN

Download key summary

Related content

Publication
Chlamydia and Gonorrhea Shifting Age Based Positivity Among Young Females 2010 2017
Publication
Impact of the COVID 19 Pandemic on Chlamydia and Gonorrhea Screening in the US
Conference Presentation
STI Testing Beyond Chlamydia trachomatis Neisseria gonorrhea Mycoplasma genitalium Trichomonas vaginalis Trends Data From a US Commercial Laboratory
Test FAQ
Chlamydia trachomatis Neisseria gonorrhoeae RNA TMA
On-Demand Webinar
A Clinical View on Diagnostics Strategies for Sexually Transmitted Infections
Publication
Summary of the 4th Annual ASTDA Workshop on Improving STI Control Efforts through Cross-Sector Collaboration

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.